USPTO serial 86646133
MMJ
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BEN, LINDSEY HEATHER
- Law office
- TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with MMJ?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Patricia L. Werner
Patricia L. Werner Kelley Drye & Warren LLP101 Park AvenueNew York, NY 10178UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | cannabidiol (CBD) derived from industrial hemp for use in the manufacture of pharmaceuticals; soluble films for use in the manufacture of delivery agents for pharmaceuticals and vitamins; consumer products, namely, body care, skin care, hair care, cosmetics, and personal care products based on CBD derived from industrial hemp, namely, creams, oils, emollients, ointments, rubs, lotions, salves, shampoos, conditioners, hair treatments, scrubs, tonners, masks, drops, oils body wash, butters, exfoliants, moisturizers, and gels; Pharmaceuticals, pharmaceutical preparations, nutraceuticals, and medicines for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; pharmaceuticals, pharmaceutical preparations, nutraceuticals, and medicines containing CBD derived from industrial hemp for the treatment of pain, palliative care, nausea and vomiting, wasting syndrome and loss of appetite in AIDS and cancer patients, anorexia nervosa, multiple sclerosis, amyotrophic lateral sclerosis, spinal cord injury, epilepsy, pain, arthritides and musculoskeletal disorders, movement disorders, glaucoma, asthma, hypertension, psychiatric disorders, anxiety, depression, sleep disorders, post-traumatic stress disorder, alcohol and opioid withdrawal symptoms, schizophrenia and psychosis, Alzheimer's disease, dementia, inflammation, inflammatory skin diseases, gastrointestinal system disorders, irritable bowel syndrome, inflammatory bowel diseases, diseases of the liver, metabolic syndrome, obesity, diabetes, diseases of the pancreas, anti-neoplastic properties, and atherosclerosis; prescription synthetic narcotics for medical use; nutritional and dietary supplements; nutritional and dietary supplements for general health and wellbeing; magnetically encoded cards, namely, membership and identification cards; magnetically encoded cards for use in connection with customer loyalty, rewards, bonus points, and discount programs; magnetically encoded identification cards for use in connection with customer loyalty, rewards, bonus points, and discount programs; consumer products, namely, edible oils; consumer products, namely, non-alcoholic beverages, namely, soft drinks, fruit drinks, vegetable drinks, and juices; consumer products, namely, smokeless vaporizer pipes and pens; online retail store wholesale services featuring CBD based pharmaceutical and body care products derived from industrial hemp; mail order buying clubs in the field of pharmaceutical products; membership services, namely, the operation and maintenance of an association promoting the interests of retail and wholesale stores in the field of medical marihuana; retail and wholesale store services featuring CBD based pharmaceutical products derived from industrial hemp; retail and wholesale store services featuring pharmaceuticals containing CBDs; promoting the goods and services of others by issuance of rewards cards related to the purchase of CBD based products; retail and wholesale store reward programs to promote the sale of pharmaceuticals containing CBDs; providing a customer loyalty program which promotes the goods and services of others by offering rewards, bonus points or discount offers; providing a website featuring information regarding political and business information regarding the cannabis industry; providing a website and online computer database featuring information regarding health; assembly of pharmaceuticals for others; customized production of pharmaceuticals, pharmaceutical products, nutraceuticals and CBD based products derived from industrial hemp; extraction of CBD derived from industrial hemp; scientific research services in the area of CBD based products derived from industrial hemp; product development services for products containing CBD based products derived from industrial hemp; research and development of products containing CBDs for others for clinical studies; operation of a web site that provides online social networking; Providing a website featuring legal information regarding cannabis and CBDs based products derived from industrial hemp | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by MMJ PHYTOTECH LIMITED
- Other trademarks owned by MMJ Bioscience Inc.
- Other trademarks owned by UNITED GREENERIES HOLDINGS LTD.
- Other trademarks in Class 005
- Similar marks named MMJ
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 9, 2018 | MAB2 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Oct 9, 2018 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Mar 13, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 13, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 21, 2018 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 20, 2018 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Aug 9, 2017 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Aug 9, 2017 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Aug 9, 2017 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 5, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 5, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 27, 2017 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Feb 8, 2017 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Jan 12, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 12, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 7, 2017 | GNS2 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | — |
| Jan 7, 2017 | GNSI | INQUIRY TO SUSPENSION E-MAILED | — |
| Jan 7, 2017 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Jan 6, 2017 | RCCK | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION | — |
| Jun 17, 2016 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jun 17, 2016 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jun 17, 2016 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 17, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 17, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 12, 2016 | ALIE | ASSIGNED TO LIE | — |
| Apr 29, 2016 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 29, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 2, 2015 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 2, 2015 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 2, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 20, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 16, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 15, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 5, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |